Sometime during the next month, the company will report 2nd quarter results. Unless the marketing effort has fallen on hard times we should have an excellent comparative quarter. 2nd quarter results for 2013 were $8.1 million in revenues, $3.3 million in recurring revenues, and a net loss of $9.7 million.
It will also be interesting to see the changes in total and institutional exposures for the 2nd quarter, which we should begin seeing shortly.
This message board is understandably quiet as we wait to see the above. Hope all is well with all of you.
Yes, given Canadian accounting practices, we could show a profit for the quarter. However, that is likely to be somewhat discounted. However, depending on the level of revenues, an operating profit is not out of the question. That would be incredibly good for us. I have to admit I never could fully understand why it needs to take 9 months to a year for a salesman at the company to become productive. I've been assuming that a majority of the salesforce hired come with some experience in marketing in the medical industry.
Glad to hear you are still in the game. I sold some shares last week, but bought back yesterday. Overall, this stock has weathered this market beat down than most of my others. Plus, it has great potential. Patience has paid off before, and it will again. GLTA longs.